Results 171 to 180 of about 73,667 (245)

HIV-1 Resistance to Dolutegravir in Benin: The Need to Improve and Strengthen Therapeutic Patient Education Strategies to Achieve the Third Objective 95 of UNAIDS 95-95-95 Target. [PDF]

Case Rep Infect Dis
Tchiakpe E, Diop-Ndiaye H, Osawe S, Toure-Kane C, Yessoufou A.   +4 more
europepmc   +1 more source

Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H. [PDF]

J Med Chem, 2016
Kankanala J, Kirby KA, Liu F, Miller L, Nagy E, Wilson DJ, Parniak MA, Sarafianos SG, Wang Z.   +8 more
europepmc   +1 more source

Enzyme Selectivity of HIV Reverse Transcriptase: Conformations, Ligands, and Free Energy Partition. [PDF]

J Phys Chem B, 2015
Kirmizialtin S, Johnson KA, Elber R.
europepmc   +1 more source

HIV-1 genetic diversity and reverse transcriptase resistance mutations in Benin before dolutegravir era, West Africa. [PDF]

PLoS One
Tchiakpe E, Keke RK, Recordon-Pinson P, Diouara AAM, Andreola ML, Bachabi M, Afangnihoun A, Gbaguidi E, Osawe S, Issiaka Maiga A, Diop-Ndiaye H, Touré-Kane C, Yessoufou A.   +12 more
europepmc   +1 more source

Research progress on HIV-1 structural proteins and antiviral therapies. [PDF]

Front Immunol
Wang H, Yuan J, Wang H.
europepmc   +1 more source

Transmitted and pretreatment drug resistance among 69 HIV-1 CRFs in China: the first systematic analysis. [PDF]

Emerg Microbes Infect
Yin X, Zhao B, An M, Wang D, Liu Z, Shang H, Han X.   +6 more
europepmc   +1 more source

Neonatal Lactic Acidosis Associated With Antiretroviral Exposure: A Case Report. [PDF]

Cureus
Mercado J, Rivera L, Droz López A, Poventud Y, Andino-Colón C.   +4 more
europepmc   +1 more source

Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-experienced people with HIV-1: a systematic literature review and network meta-analysis. [PDF]

J Comp Eff Res
Curteis T, Eddowes LA, Karlsson A, Luedke H, Rubinstein M, Hempfling M, Gurney J, Gandhi-Patel B, Unger N, Mordi U, Chen M, Jarrett J, Sherman EM, Mounzer K, Khalsa AM, Dinges WL, McKellar MS, Lipps A.   +17 more
europepmc   +1 more source

Analysis of Viral Blips Through Week 192 of the DRIVE-FORWARD and DRIVE-AHEAD Phase 3 Studies of Doravirine-Based Regimens in Adults Living With Previously Untreated HIV-1. [PDF]

Open Forum Infect Dis
Molina JM, Orkin C, Paredes R, Xu ZJ, Su FH, Asante-Appiah E, Plank RM, Lahoulou R.   +7 more
europepmc   +1 more source

Nucleoside-Analog Reverse-Transcriptase Inhibitors (NRTIs) Against Multiple Sclerosis: Comprehensive Review on a Possible Novel Therapeutic Approach. [PDF]

Neurol Int
Martinisi A, Paganetti P.
europepmc   +1 more source